JP Morgan Chase’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$179M Buy
7,230,809
+2,081,355
+40% +$61M 0.01% 733
2025
Q4
$149M Buy
5,149,454
+1,205,541
+31% +$36.2M 0.01% 779
2025
Q3
$110M Sell
3,943,913
-410,039
-9% -$10.4M 0.01% 947
2025
Q2
$106M Buy
4,353,952
+920,430
+27% +$20.2M 0.01% 910
2025
Q1
$71.3M Buy
3,433,522
+641,951
+23% +$16.1M 0.01% 1105
2024
Q4
$65.7M Sell
2,791,571
-163,708
-6% -$4.03M 0.01% 1152
2024
Q3
$75.7M Buy
2,955,279
+699,901
+31% +$17.8M 0.01% 1089
2024
Q2
$53M Buy
2,255,378
+1,124,827
+99% +$28.4M ﹤0.01% 1217
2024
Q1
$32.5M Buy
1,130,551
+797,006
+239% +$24M ﹤0.01% 1556
2023
Q4
$10.9M Buy
333,545
+104,276
+45% +$2.84M ﹤0.01% 2373
2023
Q3
$6.39M Buy
229,269
+35,724
+18% +$1.17M ﹤0.01% 2651
2023
Q2
$6.6M Buy
193,545
+8,712
+5% +$274K ﹤0.01% 2649
2023
Q1
$5.56M Buy
184,833
+168,398
+1,025% +$5.22M ﹤0.01% 2733
2022
Q4
$464K Sell
16,435
-1,452
-8% -$46.1K ﹤0.01% 4573
2022
Q3
$588K Buy
17,887
+2,633
+17% +$96.7K ﹤0.01% 4352
2022
Q2
$480K Sell
15,254
-220,225
-94% -$7.7M ﹤0.01% 4594
2022
Q1
$10.8M Sell
235,479
-219,773
-48% -$10.5M ﹤0.01% 2292
2021
Q4
$27.9M Buy
455,252
+75,140
+20% +$5.19M ﹤0.01% 1543
2021
Q3
$28.4M Buy
380,112
+41,365
+12% +$3.47M ﹤0.01% 1509
2021
Q2
$31.3M Buy
338,747
+20,895
+7% +$1.78M ﹤0.01% 1484
2021
Q1
$28.2M Buy
317,852
+224,948
+242% +$22.3M ﹤0.01% 1476
2020
Q4
$8.66M Buy
92,904
+84,565
+1,014% +$6.74M ﹤0.01% 2325
2020
Q3
$535K Sell
8,339
-5,269
-39% -$309K ﹤0.01% 3949
2020
Q2
$709K Buy
13,608
+2,947
+28% +$126K ﹤0.01% 3699
2020
Q1
$334K Buy
10,661
+2,438
+30% +$81.5K ﹤0.01% 4037
2019
Q4
$276K Buy
+8,223
New +$261K ﹤0.01% 4548

Other funds holding ARKG